Picture of Little Green Pharma logo

LGP Little Green Pharma Income Statement

0.000.00%
au flag iconLast trade - 00:00
HealthcareAdventurousMicro CapSuper Stock

Annual income statement for Little Green Pharma, fiscal year end - March 31st, AUD millions except per share, conversion factor applied.

2020
June 30th
R2021
June 30th
2022
March 31st
2023
March 31st
2024
March 31st
Period Length:12 M12 M9 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue2.2710.519.925.6
Cost of Revenue
Gross Profit1.124.243.3810.113.6
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses9.48-11.929.532.234.8
Operating Profit-7.2818.9-19-12.3-9.16
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes-9.3222.2-18.1-8.56-8.15
Provision for Income Taxes
Net Income After Taxes-9.3222.2-18.1-8.56-8.15
Net Income Before Extraordinary Items
Extraordinary Items
Net Income-9.3222.2-18.3-9.21-8.15
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income-9.3222.2-18.3-9.21-8.15
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-0.076-0.015-0.086-0.034-0.025
Dividends per Share